These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 30449201)

  • 1. Incretin-based therapy for diabetic ulcers: from bench to bedside.
    Ku HC; Liang YJ
    Expert Opin Investig Drugs; 2018 Dec; 27(12):989-996. PubMed ID: 30449201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clarifying the role of incretin-based therapies in the treatment of type 2 diabetes mellitus.
    Campbell RK
    Clin Ther; 2011 May; 33(5):511-27. PubMed ID: 21665040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AMP-activated protein kinase activators in diabetic ulcers: from animal studies to Phase II drugs under investigation.
    Lin JT; Chen HM; Chiu CH; Liang YJ
    Expert Opin Investig Drugs; 2014 Sep; 23(9):1253-65. PubMed ID: 24857754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathophysiological background for incretin therapy: is it capable of more than we think?].
    Haluzík M; Urbanová M; Haluzíková D; Trachta P
    Vnitr Lek; 2011 Nov; 57(11):897-902. PubMed ID: 22165692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic reviews of wound care management: (3) antimicrobial agents for chronic wounds; (4) diabetic foot ulceration.
    O'Meara S; Cullum N; Majid M; Sheldon T
    Health Technol Assess; 2000; 4(21):1-237. PubMed ID: 11074391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incretin-based therapies for type 2 diabetes mellitus: current status and future prospects.
    Drab SR
    Pharmacotherapy; 2010 Jun; 30(6):609-24. PubMed ID: 20500049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular Effects of Incretin-Based Therapies.
    White WB; Baker WL
    Annu Rev Med; 2016; 67():245-60. PubMed ID: 26768240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacology of incretin therapies for type 2 diabetes mellitus: implications for treatment.
    Neumiller JJ
    Clin Ther; 2011 May; 33(5):528-76. PubMed ID: 21665041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing Diabetic Foot Ulcers: Pharmacotherapy for Wound Healing.
    Dixon D; Edmonds M
    Drugs; 2021 Jan; 81(1):29-56. PubMed ID: 33382445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. beta-cell failure in diabetes and preservation by clinical treatment.
    Wajchenberg BL
    Endocr Rev; 2007 Apr; 28(2):187-218. PubMed ID: 17353295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Incretin and incretin-based therapies].
    Harada N; Inagaki N
    Nihon Rinsho; 2010 May; 68(5):931-42. PubMed ID: 20446595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential New Approaches to Modifying Intestinal GLP-1 Secretion in Patients with Type 2 Diabetes Mellitus : Focus on Bile Acid Sequestrants.
    Holst JJ; McGill MA
    Clin Drug Investig; 2012 Jan; 32(1):1-14. PubMed ID: 27933595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood pressure-lowering effects of incretin-based diabetes therapies.
    Lovshin JA; Zinman B
    Can J Diabetes; 2014 Oct; 38(5):364-71. PubMed ID: 25284699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the incretin system in type 2 diabetes mellitus.
    Potenza M; Rayfield EJ
    Mt Sinai J Med; 2009 Jun; 76(3):244-56. PubMed ID: 19421968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incretin actions and consequences of incretin-based therapies: lessons from complementary animal models.
    Renner S; Blutke A; Streckel E; Wanke R; Wolf E
    J Pathol; 2016 Jan; 238(2):345-58. PubMed ID: 26455904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular effects of incretins in diabetes.
    Advani A; Bugyei-Twum A; Connelly KA
    Can J Diabetes; 2013 Oct; 37(5):309-14. PubMed ID: 24500557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An updated review on cancer risk associated with incretin mimetics and enhancers.
    Tseng CH; Lee KY; Tseng FH
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2015; 33(1):67-124. PubMed ID: 25803196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropathic diabetic foot ulcers treated with cerium dioxide nanoparticles: A case report.
    Kobyliak N; Abenavoli L; Kononenko L; Kyriienko D; Spivak M
    Diabetes Metab Syndr; 2019; 13(1):228-234. PubMed ID: 30641702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Incretin-based antidiabetic treatment and diseases of the pancreas (pancreatitis, pancreas carcinoma)].
    Jermendy G
    Orv Hetil; 2016 Apr; 157(14):523-8. PubMed ID: 27017851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular safety of combination therapies with incretin-based drugs and metformin compared with a combination of metformin and sulphonylurea in type 2 diabetes mellitus--a retrospective nationwide study.
    Mogensen UM; Andersson C; Fosbøl EL; Schramm TK; Vaag A; Scheller NM; Torp-Pedersen C; Gislason G; Køber L
    Diabetes Obes Metab; 2014 Oct; 16(10):1001-8. PubMed ID: 24827939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.